Zucara Therapeutics Announces Publication of Preclinical Study Demonstrating ZT-01's Ability to Restore Glucagon Release in Type 1 Diabetes

/PRNewswire/ - Zucara Therapeutics Inc., a diabetes life sciences company developing the first once-daily therapeutic to prevent insulin-induced hypoglycemia...

Related Keywords

Toronto ,Ontario ,Canada ,Richard Liggins ,Owen Chan ,Michaelc Riddell At York University ,University Of Utah ,Zucara Therapeutics Inc ,Therapeutics Inc ,Novel Somatostatin Receptor ,Glucagon Response ,Zucara Therapeutics ,York University ,Zucara Therapeutic Chief Scientific ,